betulinic acid and enfuvirtide

betulinic acid has been researched along with enfuvirtide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CH; Cosentino, LM; Kashiwada, Y; Lee, KH; Shen, JK; Sun, IC; Wang, HK; Yang, LM	1
Cai, L; Jiang, S; Jiang, X; Li, J; Li, X; Liang, G; Liu, K; Lu, L; Na, H; Wang, C; Wang, Q; Xu, X; Yu, F; Zhang, T; Zhang, Z; Zheng, B	1

Other Studies

2 other study(ies) available for betulinic acid and enfuvirtide

Article	Year
Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. Journal of medicinal chemistry, 1998, Nov-05, Volume: 41, Issue:23 Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Fusion; Cell Line; Glutarates; HeLa Cells; HIV-1; Humans; Lymphocytes; Mice; Structure-Activity Relationship; Triterpenes; Virus Replication	1998
Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics. Journal of medicinal chemistry, 2014, Sep-11, Volume: 57, Issue:17 Topics: Amino Acid Sequence; Antiviral Agents; Cell Line; Cell Line, Tumor; Cell Survival; Enfuvirtide; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV-1; Humans; Models, Chemical; Models, Molecular; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Protein Structure, Secondary; Sapogenins; Structure-Activity Relationship	2014

Article

Year

Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.

Journal of medicinal chemistry, 1998, Nov-05, Volume: 41, Issue:23

Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Fusion; Cell Line; Glutarates; HeLa Cells; HIV-1; Humans; Lymphocytes; Mice; Structure-Activity Relationship; Triterpenes; Virus Replication

1998

Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics.

Journal of medicinal chemistry, 2014, Sep-11, Volume: 57, Issue:17

Topics: Amino Acid Sequence; Antiviral Agents; Cell Line; Cell Line, Tumor; Cell Survival; Enfuvirtide; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV-1; Humans; Models, Chemical; Models, Molecular; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Protein Structure, Secondary; Sapogenins; Structure-Activity Relationship

2014